-
the Eddie Goldenberg Research Chairs of Canada award (https://www.canada.ca/en/impact-plus-chairs.html) is formally accepted (July 1st 2026). Applicants may apply regardless of their current location; however
-
of Assistant Professor at UBC. Under the Canada Impact+ Emerging Leaders program, nominees must be working and residing outside Canada when the Eddie Goldenberg Research Chairs of Canada award (https
-
Lunenfeld-Tanenbaum Research Institute | Central Toronto Roselawn, Ontario | Canada | about 12 hours ago
adaptations; disease modeling and the pathophysiology of pregnancy-associated complications (e.g., preeclampsia, preterm birth, gestational diabetes); therapeutic discovery; and the developmental origins
-
autoimmune and inflammatory diseases of the central nervous system, including multiple sclerosis, neuromyelitis optica spectrum disorders (NMOSD), MOG antibody-associated disease (MOGAD), autoimmune
-
Academic Job Category Faculty Non Bargaining Job Title Research Associate Department Janjua Laboratory | Centre for Disease Control | Faculty of Medicine (Naveed Janjua) Posting End Date September
-
and hiring process or for more information and support, please visit UBC’s Center For Workplace Accessibility website at https://hr.ubc.ca/health-and-wellbeing/working-injury-illness-ordisability/centre
-
and support, please visit UBC’s Center For Workplace Accessibility website at https://hr.ubc.ca/health-and-wellbeing/working-injury-illness-or-disability/centre-workplace-accessibility or contact
-
focused on understanding how innate immune cells contribute to disease progression and recovery within the central nervous system. A major goal of the position is to develop new mechanistic insights
-
or Associate Professor (Clinical) specializing in Adult Epilepsy. We welcome applications from outstanding clinical epileptologists (MD) and clinician-scientists (MD/PhD). The professorial rank will be
-
(genetically modified mice) of human demyelinating disease. Analyzing oligodendrocyte maturation and migration during development, and using the lysophosphatidyl choline (LPC) mouse model of demyelination